Safety, tolerability, and efficacy of NLY01 in early untreated Parkinson's disease: a randomised, double-blind, placebo-controlled trial.
A. McGarry, Shane Rosanbalm, Mika Leinonen, C. Olanow +24 more
2024Lancet Neurology98 citations
Semantic Scholar

